CVM · Company research
Cel-Sci Corporation (CVM): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Cel-Sci Corporation (CVM) Jumps 11.98% to $2.71 as Buyers Push Toward Resistance - Dividend ETF - https://www.dars.gov.et/ | Cel-Sci Corporation (CVM) Jumps 11.98% to $2.71 as Buyers Push Toward Resistance - Dividend ETF https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 6, 2026 | neutral | 0 | 0.6 |
| Cel-Sci Corporation (CVM) Jumps 11.98% to $2.71 as Buyers Push Toward Resistance - ETF AUM Growth - siam.in | Cel-Sci Corporation (CVM) Jumps 11.98% to $2.71 as Buyers Push Toward Resistance - ETF AUM Growth siam.in | View source ↗ | siam.in | Oct 6, 2026 | neutral | 0 | 0.6 |
| A 2,082-share award brings CEL SCI CORP (CVM) CFO Patricia B. Prichep's direct holding to 19,571 shares. - Stock Titan | A 2,082-share award brings CEL SCI CORP (CVM) CFO Patricia B. Prichep's direct holding to 19,571 shares. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| CEL SCI (CVM) CEO adds 100K restricted shares to his stake - Stock Titan | CEL SCI (CVM) CEO adds 100K restricted shares to his stake Stock Titan | View source ↗ | Stock Titan | Aug 26, 2026 | neutral | 0 | 0.6 |
| 73% Five-Year Survival: Which Patients Will CEL-SCI Study Next? - Stock Titan | 73% Five-Year Survival: Which Patients Will CEL-SCI Study Next? Stock Titan | View source ↗ | Stock Titan | Aug 17, 2026 | neutral | 0 | 0.6 |
| CVM Forecast — Price Target — Prediction for 2027 - TradingView | CVM Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jul 25, 2026 | neutral | 0 | 0.6 |
| CVM Q4 2024 Earnings: Narrower-than-Expected Loss Boosts Stock - Dividend Increase Stocks - dars.gov.et | CVM Q4 2024 Earnings: Narrower-than-Expected Loss Boosts Stock - Dividend Increase Stocks dars.gov.et | View source ↗ | dars.gov.et | Jul 19, 2026 | neutral | 0 | 0.6 |
| $CVM stock is up 17% today. Here's what we see in our data. - Quiver Quantitative | $CVM stock is up 17% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 6, 2026 | neutral | 0 | 0.6 |
| CEL-SCI Completes $2.5M Stock Offering at $1.00, Engages ThinkEquity as Placement Agent - TradingView | CEL-SCI Completes $2.5M Stock Offering at $1.00, Engages ThinkEquity as Placement Agent TradingView | View source ↗ | TradingView | Jun 16, 2026 | neutral | 0 | 0.6 |
| CVM Stock Sinks In Pre-Market Trading After Announcing Second Equity Raise For Its Cancer Drug In Just Over A Month - Stocktwits | CVM Stock Sinks In Pre-Market Trading After Announcing Second Equity Raise For Its Cancer Drug In Just Over A Month Stocktwits | View source ↗ | Stocktwits | Jun 15, 2026 | neutral | 0 | 0.6 |
| CEL-SCI Raises $7.2 Million in Stock Offering; Placement Agreement With ThinkEquity - TradingView | CEL-SCI Raises $7.2 Million in Stock Offering; Placement Agreement With ThinkEquity TradingView | View source ↗ | TradingView | May 13, 2026 | neutral | 0 | 0.6 |
| $CVM stock is down 26% today. Here's what we see in our data. - Quiver Quantitative | $CVM stock is down 26% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | May 1, 2026 | neutral | 0 | 0.6 |
| Why DID CVM Shares Rally Over 7% Today? - Stocktwits | Why DID CVM Shares Rally Over 7% Today? Stocktwits | View source ↗ | Stocktwits | Jan 26, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Jan 22, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.